FORA - Forian Operating profit EBITDA

Brandmark of Forian (FORA)

Strong confidence from pharmaceutical behemoths in Forian Inc. (FORA) intelligence is driving growth, as evidenced by the EBITDA chart. The 0.00 mark captures this metric, which relies on stable subscriptions that eliminate commodity risks. However, regulatory restrictions on the cross-border transfer of medical data are exerting pressure on the recovery dynamics of the company's core operations.

Forian Corporation (FORA) - Operating profit before deduction of amortization from 11/23/2025 to 05/30/2026

Summary analytical data breakdowns for Forian (FORA)

- stock value and consensus price forecast:
Market Chart Forian Corporation|FORA - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Forian|FORA - Total Company Value
- book value of equity indicators:
Equity per Share Forian|FORA - Company Net Assets|Market Value to Book Value forian.com|FORA - Company Total Assets
- debt level and financial liquidity data:
Total Debt to Capital Coefficient Forian Inc.|FORA - Long-Term Debt to Equity|Short-Term Debt to Capital Ratio Forian, Inc.|FORA - Company Aggregate Debts|Debt to Book Value Forian|FORA - Company Long-Term Liabilities|Short-Term Debt Volume Forian|Critical Liquidity Ratio forian.com
- earnings and valuation multiples indicators:
FORA - Company Net Income|Expected Net Profit Forian Inc.|FORA - Price to Earnings Ratio|Future Price to Earnings Multiple forian.com|FORA - PEG Multiple|EV/EBITDA Multiple Forian|FORA - Operating profit EBITDA|Earnings per share for the last 12 months Forian|FORA - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth forian.com|FORA - Net earnings per share growth this year|Projected earnings per share increase next year Forian Inc.
Summary company analytics:FORA - Forian Corporation
Signature product of Forian Corporation

This metric assesses the business's actual ability to generate cash flow before depreciation and taxes, separating fundamental growth from market speculation. For Forian Inc. (FORA), this indicator reflects the monetization of implementing big data parsing software algorithms; therefore, the EBITDA cash volume trend allows for an objective measurement of the commercial efficiency of real-time automated analytics.

Competitor analysis for Forian Inc.

Operating income before deduction of amortization Reed Elsevier (RELX)|CoStar Group, Inc. - Operating profit EBITDA|VRSK - Operating profit EBITDA|Equifax (EFX) - Profit before payment of interest, taxes and amortization|Operating profit before amortization IT|Operating profit before deduction of amortization TRU|FDS: Income before deduction of interest, taxes and amortization|Operating profit EBITDA MORN|Operating income before deduction of amortization ZoomInfo Technologies|Profit before payment of interest, taxes and amortization Planet Labs PL|CLVT: Operating profit before amortization|Innodata Corp - Operating profit EBITDA|Similarweb Platform (SMWB) - Operating profit before deduction of amortization|PDFS (PDF Solutions, Inc.) - Operating profit before deduction of amortization|TTGT - Operating income before deduction of amortization|FORR (Forrester Research, Inc.) - Operating profit EBITDA|FiscalNote Holdings, Inc. - Profit before deduction of interest, taxes, depreciation and amortization|Profit before payment of interest, taxes and amortization Dun & Bradstreet Holdings Inc. (DNB)|MTTR - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization ZoomInfo Technologies Inc. ZI